Clinical trial
Targeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder
NCT02855762 is registered in ClinicalTrials.gov with Melvin McInnis, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Targeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder
- Lead sponsor
- Melvin McInnis, MD
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 8, 2016
- Completion date
- January 31, 2019
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.